BSE Live
Sep 08, 16:01Prev. Close
255.95
Open Price
256.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Profit & Loss account of Trident Texofab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 122.06 | 99.48 | 96.37 | 84.29 | 52.43 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.01 | 0.00 | 2.50 | |
Revenue From Operations [Net] | 122.06 | 99.48 | 96.36 | 84.29 | 49.93 | |
Total Operating Revenues | 122.06 | 99.48 | 96.36 | 84.29 | 49.93 | |
Other Income | 3.30 | 0.39 | 1.90 | 0.74 | 1.85 | |
Total Revenue | 125.36 | 99.87 | 98.26 | 85.03 | 51.78 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 18.68 | 19.63 | 23.58 | 14.31 | 5.29 | |
Purchase Of Stock-In Trade | 89.02 | 66.76 | 60.75 | 57.00 | 34.09 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -1.88 | -2.56 | -3.94 | 0.95 | 2.68 | |
Employee Benefit Expenses | 2.87 | 2.69 | 2.77 | 2.40 | 1.96 | |
Finance Costs | 4.55 | 4.04 | 3.71 | 2.83 | 2.85 | |
Depreciation And Amortisation Expenses | 1.65 | 1.65 | 1.64 | 1.47 | 1.02 | |
Other Expenses | 7.90 | 6.80 | 6.89 | 4.85 | 3.03 | |
Total Expenses | 122.78 | 99.01 | 95.40 | 83.80 | 50.92 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2.58 | 0.86 | 2.86 | 1.23 | 0.86 | |
Exceptional Items | 0.00 | 0.31 | -0.13 | 0.04 | 0.05 | |
Profit/Loss Before Tax | 2.58 | 1.17 | 2.73 | 1.27 | 0.90 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.07 | 0.36 | 0.10 | 0.00 | 0.18 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.27 | 0.41 | 0.29 | 0.37 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 0.07 | 0.09 | 0.51 | 0.29 | 0.55 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 2.51 | 1.08 | 2.22 | 0.98 | 0.35 | |
Profit/Loss From Continuing Operations | 2.51 | 1.08 | 2.22 | 0.98 | 0.35 | |
Profit/Loss For The Period | 2.51 | 1.08 | 2.22 | 0.98 | 0.35 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 2.38 | 1.07 | 2.20 | 0.98 | 0.35 | |
Diluted EPS (Rs.) | 2.09 | 1.07 | 2.20 | 0.98 | 0.35 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 19.63 | 23.58 | 14.31 | 5.29 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.14 | 0.09 | 0.05 | 0.02 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017